Literature DB >> 11188970

Complications and limitations of drug therapy for Parkinson's disease.

J Jankovic1.   

Abstract

Levodopa is the most effective drug treatment for Parkinson's disease (PD). However, its chronic use is associated with dyskinesia, motor fluctuations, and hallucinations. There are various approaches to the management of levodopa complications. Motor fluctuations can be treated with a long-acting levodopa preparation, liquid levodopa, or the addition of dopamine agonists or catechol-O-methyl transferase (COMT) inhibitors. Drugs that may improve levodopa-induced psychiatric complications are olanzapine, clozapine, and ondansetron. A large proportion of patients with long-standing PD cannot be controlled adequately with the available pharmacologic tools and are candidates for surgery. Pallidotomy and deep brain stimulation (DBS) of the globus pallidum pars interna and the subthalamic nucleus are currently the preferred surgical approaches. Appropriate patient selection becomes a critical issue for achieving the best surgical results.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11188970

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

Review 1.  An update on gene therapy in Parkinson's disease.

Authors:  Jennifer Witt; William J Marks
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

2.  Anaesthetic Management of a Geriatric Patient with Parkinson's Disease, who was Posted for Emergency Laparotomy- A Case Report.

Authors:  Renuka T Holyachi; Santosh Karajagi; Siddanagouda M Biradar
Journal:  J Clin Diagn Res       Date:  2013-01-01

3.  Neuroprotection in Parkinson's disease; a commentary.

Authors:  Emilia Mabel Gatto; Natalia Riobó; María Cecilia Carreras; Juan José Poderoso; Federico E Micheli
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

4.  Amelioration of L-Dopa-Associated Dyskinesias with Triterpenoic Acid in a Parkinsonian Rat Model.

Authors:  Babongile C Ndlovu; Willie M U Daniels; Musa V Mabandla
Journal:  Neurotox Res       Date:  2015-10-12       Impact factor: 3.911

5.  Treatment of idiopathic Parkinson's disease with traditional chinese herbal medicine: a randomized placebo-controlled pilot clinical study.

Authors:  Wan Fung Kum; Siva Sundara Kumar Durairajan; Zhao Xiang Bian; Sui Cheung Man; Yuen Chi Lam; Li Xia Xie; Jia Hong Lu; Yan Wang; Xian Zhang Huang; Min Li
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-18       Impact factor: 2.629

6.  Anesthesia implications in emergency oncologic surgery in a case of untreated Parkinsonism.

Authors:  Sukhwinder Kaur Bajwa; Sukhminder Jit Singh Bajwa; Jasbir Kaur; Anita Singh
Journal:  Saudi J Anaesth       Date:  2011-07

7.  The therapeutic potential of stem cells and progenitor cells for the treatment of Parkinson's disease.

Authors:  Mooi Tiong Liau; Farahnaz Amini; Thamil Selvee Ramasamy
Journal:  Tissue Eng Regen Med       Date:  2016-10-20       Impact factor: 4.169

Review 8.  Treadmill training for patients with Parkinson's disease.

Authors:  Jan Mehrholz; Joachim Kugler; Alexander Storch; Marcus Pohl; Kathleen Hirsch; Bernhard Elsner
Journal:  Cochrane Database Syst Rev       Date:  2015-09-13

Review 9.  Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease.

Authors:  Bernhard Elsner; Joachim Kugler; Marcus Pohl; Jan Mehrholz
Journal:  Cochrane Database Syst Rev       Date:  2016-07-18

10.  Effects of transcranial direct current stimulation on gait in people with Parkinson's disease: study protocol for a randomized, controlled clinical trial.

Authors:  Vida Alizad; Marcus Meinzer; Laurent Frossard; Remco Polman; Simon Smith; Graham Kerr
Journal:  Trials       Date:  2018-11-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.